Skip to main navigation Skip to search Skip to main content

A Double-Blind, Placebo-Controlled, Randomized Trial of Oral Rofecoxib at the Initiation of Interferon Beta-1a Therapy in Multiple Sclerosis or First Demyelinating Event

  • Mejico, Luis (PI)
  • Friedman, Deborah I (CoPI)
  • Mihai, Cornelia (CoPI)

Project: Research

Project Details

StatusFinished
Effective start/end date10/24/01 → 10/23/04

Funding

  • Biogen IDEC: $15,750.00